Sweden
BioReperia is a Swedish startup that is revolutionizing the fields of drug discovery and cancer treatment with its unique ZTX® platform (zebrafish tumor xenograft). The company's slogan, "Accelerating drug discovery and predicting the best cancer treatment for you!", encapsulates its mission to personalize and expedite cancer treatment. BioReperia's innovative approach allows for the rapid identification of the most effective drugs for individual cancer patients, significantly reducing the prediction time from 6 months to 5 days.
Founded in 2015, BioReperia is a leading contract research organization (CRO) in the biopharma and biotechnology industries. The company's groundbreaking platform offers in vivo data on tumor regression and metastasis inhibition within a week, providing a swift and accurate assessment of drug candidates. This agile and highly customizable toolbox for drug discovery holds the potential to enhance the success rate in clinical trials and improve cancer diagnosis.
Their most recent investment of kr8.00M came through a Series A investment on 22 May 2019, with Almi Invest and Hemex as the participating investors. This funding is a testament to the confidence that notable investors have in BioReperia's pioneering approach to revolutionize cancer treatment and drug discovery. With its headquarters in Sweden, BioReperia is poised to be a gamechanger in the biopharma and biotechnology landscape.
With lead products designed for precision medicine (ZTX®Predict) and drug discovery (ZTX®Oncoleads), BioReperia is on a mission to collaborate and make a significant impact in the fight against cancer. The company's commitment to saving time and financial resources while providing personalized and effective treatment options positions them as a key player in the future of cancer therapeutics.
For those looking to collaborate or learn more about BioReperia's innovative solutions, reaching out to the company at [email protected] is the first step toward potentially transforming the landscape of cancer treatment.
